[go: up one dir, main page]

CO4290423A1 - Aminoalcanimidazoles y -triazoles acilados - Google Patents

Aminoalcanimidazoles y -triazoles acilados

Info

Publication number
CO4290423A1
CO4290423A1 CO95021039A CO95021039A CO4290423A1 CO 4290423 A1 CO4290423 A1 CO 4290423A1 CO 95021039 A CO95021039 A CO 95021039A CO 95021039 A CO95021039 A CO 95021039A CO 4290423 A1 CO4290423 A1 CO 4290423A1
Authority
CO
Colombia
Prior art keywords
aminoalcanimidazoles
acilated
triazoles
piridilo
alkyl
Prior art date
Application number
CO95021039A
Other languages
English (en)
Inventor
Ingeborg Schuster
Helmut Egger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO4290423A1 publication Critical patent/CO4290423A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1. UN COMPUESTO DE FORMULA FIGURA 1 CARACTERIZADO PORQUE R1 REPRESENTA FENILO, NAFTI- LO, TIENILO O PIRIDILO, POR LO QUE ESOS CUATRO SUSTITUYENTES SE ENCUENTRAN OPCIONALMENTE MONOSUS- TITUIDOS POR HALOGENO, ALCOXI, ALQUILO, DIALQUIL- AMINO O CIANO Y R2 REPRESENTA HIDROGENO; O R1 REPRESENTA HIDROGENO Y R2 REPRESENTA PIRIDILO O 2-(5-CLORO)PIRIDILO; R3 REPRESENTA HIDROGENO, HA- LOGENO, ALQUILO, CIANO, ALCOXICARBONILO, ALQUIL- CARBONILO, O AMINO OPCIONALMENTE SUSTITUIDO; Y X REPRESENTA CH o N; EN FORMA LIBRE O EN FORMA DE SAL.
CO95021039A 1994-05-18 1995-05-17 Aminoalcanimidazoles y -triazoles acilados CO4290423A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9409882A GB9409882D0 (en) 1994-05-18 1994-05-18 Organic compounds

Publications (1)

Publication Number Publication Date
CO4290423A1 true CO4290423A1 (es) 1996-04-17

Family

ID=10755289

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95021039A CO4290423A1 (es) 1994-05-18 1995-05-17 Aminoalcanimidazoles y -triazoles acilados

Country Status (30)

Country Link
US (1) US5622982A (es)
EP (1) EP0683156B1 (es)
JP (1) JP2912566B2 (es)
KR (1) KR100371465B1 (es)
CN (1) CN1060163C (es)
AT (1) ATE164576T1 (es)
AU (1) AU696880B2 (es)
BR (1) BR9502062A (es)
CA (1) CA2149459C (es)
CO (1) CO4290423A1 (es)
CZ (1) CZ285385B6 (es)
DE (1) DE69501915T2 (es)
DK (1) DK0683156T3 (es)
ES (1) ES2114289T3 (es)
FI (1) FI112364B (es)
GB (1) GB9409882D0 (es)
GR (1) GR3026505T3 (es)
HK (1) HK1008743A1 (es)
HU (1) HUT72063A (es)
IL (1) IL113743A (es)
MY (1) MY135559A (es)
NO (1) NO304738B1 (es)
NZ (1) NZ272129A (es)
PE (1) PE14896A1 (es)
PH (1) PH31510A (es)
RU (1) RU2152933C2 (es)
SI (1) SI0683156T1 (es)
SK (1) SK280326B6 (es)
TW (1) TW351718B (es)
ZA (1) ZA954074B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0708771T3 (da) * 1993-07-15 1999-06-21 Pfizer Benzyloxyquinuclidiner som substans P antagonister
WO1997018817A1 (fr) * 1995-11-20 1997-05-29 Kiyoshi Kita Preparation externe contenant de la vitamine d ou de la vitamine k
AU2792997A (en) * 1997-05-26 1998-12-30 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
TW575562B (en) * 1998-02-19 2004-02-11 Agrevo Uk Ltd Fungicides
IL129596A (en) * 1998-05-08 2003-10-31 Dow Agrosciences Llc Preparation of 2-substituted pyridines
GB0029524D0 (en) * 2000-12-04 2001-01-17 Univ Sheffield Disease treatment
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments
US7429604B2 (en) * 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
WO2006032299A1 (en) * 2004-09-24 2006-03-30 Susanna Miettinen Use of inhibitors of 24-hydroxylase in the treatment of cancer
WO2006036892A2 (en) * 2004-09-24 2006-04-06 Sapphire Therapeutics, Inc. Use of inhibitors of 24-hydroxylase in the treatment of cancer
CN104530038A (zh) * 2014-12-10 2015-04-22 沈阳药科大学 酰胺咪唑类衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
US4191767A (en) * 1977-01-07 1980-03-04 Westwood Pharmaceuticals, Inc. Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines
CH655103A5 (de) * 1983-03-11 1986-03-27 Sandoz Ag Azolderivate, verfahren zu ihrer herstellung und ihre verwendung.
CH677925A5 (es) * 1986-12-03 1991-07-15 Sandoz Ag

Also Published As

Publication number Publication date
EP0683156B1 (en) 1998-04-01
PE14896A1 (es) 1996-05-09
ATE164576T1 (de) 1998-04-15
FI112364B (fi) 2003-11-28
FI952383A0 (fi) 1995-05-16
US5622982A (en) 1997-04-22
CA2149459A1 (en) 1995-11-19
ZA954074B (en) 1996-11-18
PH31510A (en) 1998-11-03
SK280326B6 (sk) 1999-11-08
TW351718B (en) 1999-02-01
BR9502062A (pt) 1996-04-30
DE69501915T2 (de) 1998-08-27
CZ126595A3 (en) 1995-11-15
DE69501915D1 (de) 1998-05-07
KR100371465B1 (ko) 2003-03-19
SK63595A3 (en) 1995-12-06
KR950032147A (ko) 1995-12-20
CA2149459C (en) 2006-09-19
GB9409882D0 (en) 1994-07-06
AU2008995A (en) 1995-11-23
IL113743A0 (en) 1995-08-31
RU2152933C2 (ru) 2000-07-20
CZ285385B6 (cs) 1999-07-14
JPH0853422A (ja) 1996-02-27
MY135559A (en) 2008-05-30
FI952383L (fi) 1995-11-19
HUT72063A (en) 1996-03-28
NO951944D0 (no) 1995-05-16
EP0683156A1 (en) 1995-11-22
ES2114289T3 (es) 1998-05-16
NO304738B1 (no) 1999-02-08
CN1120039A (zh) 1996-04-10
HU9501451D0 (en) 1995-06-28
IL113743A (en) 1999-08-17
AU696880B2 (en) 1998-09-24
JP2912566B2 (ja) 1999-06-28
NO951944L (no) 1995-11-20
GR3026505T3 (en) 1998-07-31
HK1008743A1 (en) 1999-05-14
RU95107652A (ru) 1997-03-20
CN1060163C (zh) 2001-01-03
NZ272129A (en) 1996-05-28
DK0683156T3 (da) 1998-10-19
SI0683156T1 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
ES520300A0 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas.
CO4290423A1 (es) Aminoalcanimidazoles y -triazoles acilados
SE7908727L (sv) Fosfinylalkanoylproliner
DE3468878D1 (en) 7-amino-azoloû1,5-a¨pyrimidines and fungicides containing them
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
NO970092D0 (no) Dihydrobenzofuraner
NO972909L (no) Substituerte azetidin-2-oner for behandling av atherosklerose
UY25986A1 (es) Complejo del inhibidor de ras-farnesiltransferasa y sulfobutiléter-7-beta-ciclodextrina o 2-hidroxipropil-beta-ciclodextrina y método.
DK170188A (da) Carbinolderivater
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DK0516234T3 (da) Phenoxyphenylderivater
DE3360904D1 (de) A fungicidal indanylbenzamide
GR1000373B (el) Μεθοδος παρασκευης νεων παραγωγων 1,4-βενζοξαζινης και 1,4-βεν ζοθειαζινης
DE3572816D1 (de) Pyridazinone inotropic agents
BG104309A (en) 8-azabicyclo[3,2,1]octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
DK0379085T3 (da) Phenylalkyminer og fungicider indeholdende disse
ATE42099T1 (de) Benzodisultame.
ES2055465T3 (es) Nuevos piridinmetanoles 3-substituidos y los fungicidas que les contienen.
ECSP951447A (es) Aminoalcanimidazoles y triazoles acilados
ATE15201T1 (de) Organophosphat-derivate.
TW340788B (en) Ester compounds and household insects-controlling agents containing the same as an active ingredient
GR79583B (es)
HK1004546A1 (en) Aminoalcohols useful as optical resolving agents
AU1147383A (en) Substituted oximoacetanilides
SG47940A1 (en) Light screening agent